[Biomaterials and public health: avoid the drift].

The difficulties found in the maturation of the Science of Biomaterials are analysed at the different levels: research, education, industry, reglementary and legislative environment, needs of hospitals and private practices. Proposals are made for a better response to the needs of an area which should have a growth at least as important as that of drugs.